Clinical Trials List
Protocol NumberBGB-A317-305
Completed
2018-12-13 - 2024-08-27
Phase III
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Chung-Pin Li Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 趙盈瑞 Division of Hematology & Oncology
- Yan-Shen Shan Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
720 participants
